Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 18

1.

Delay of simian human immunodeficiency virus infection and control of viral replication in vaccinated macaques challenged in the presence of a topical microbicide.

Cheng-Mayer C, Huang Y, Gettie A, Tsai L, Ren W, Shakirzyanova M, Sina ST, Trunova N, Blanchard J, Jenkins LM, Lo Y, Schito ML, Appella E.

AIDS. 2011 Sep 24;25(15):1833-41. doi: 10.1097/QAD.0b013e32834a1d94.

2.

Small-molecule inactivation of HIV-1 NCp7 by repetitive intracellular acyl transfer.

Miller Jenkins LM, Ott DE, Hayashi R, Coren LV, Wang D, Xu Q, Schito ML, Inman JK, Appella DH, Appella E.

Nat Chem Biol. 2010 Dec;6(12):887-9. doi: 10.1038/nchembio.456. Epub 2010 Oct 17.

3.

Towards developing standardized protocols for evaluation of cellular mucosal immune responses - Recommendations from a DAIDS/NIH workshop, June 15-16, 2009.

Mehra V, Musib R, Schito ML.

Vaccine. 2010 Jul 5;28(30):4689-94. doi: 10.1016/j.vaccine.2010.04.092. Epub 2010 May 14.

PMID:
20470800
4.

Challenges for rapid molecular HIV diagnostics.

Schito ML, D'Souza MP, Owen SM, Busch MP.

J Infect Dis. 2010 Apr 15;201 Suppl 1:S1-6. doi: 10.1086/650394.

5.

Human immunodeficiency virus type 1 nucleocapsid inhibitors impede trans infection in cellular and explant models and protect nonhuman primates from infection.

Wallace GS, Cheng-Mayer C, Schito ML, Fletcher P, Miller Jenkins LM, Hayashi R, Neurath AR, Appella E, Shattock RJ.

J Virol. 2009 Sep;83(18):9175-82. doi: 10.1128/JVI.00820-09. Epub 2009 Jul 8.

6.

Topical microbicides: a promising approach for controlling the AIDS pandemic via retroviral zinc finger inhibitors.

Turpin JA, Schito ML, Jenkins LM, Inman JK, Appella E.

Adv Pharmacol. 2008;56:229-56. Review. No abstract available.

PMID:
18086414
7.

Preclinical evaluation of a zinc finger inhibitor targeting lentivirus nucleocapsid protein in SIV-infected monkeys.

Schito ML, Soloff AC, Slovitz D, Trichel A, Inman JK, Appella E, Turpin JA, Barratt-Boyes SM.

Curr HIV Res. 2006 Jul;4(3):379-86.

PMID:
16842089
8.

Wip1 phosphatase-deficient mice exhibit defective T cell maturation due to sustained p53 activation.

Schito ML, Demidov ON, Saito S, Ashwell JD, Appella E.

J Immunol. 2006 Apr 15;176(8):4818-25.

9.
11.

In vivo antiviral activity of novel human immunodeficiency virus type 1 nucleocapsid p7 zinc finger inhibitors in a transgenic murine model.

Schito ML, Goel A, Song Y, Inman JK, Fattah RJ, Rice WG, Turpin JA, Sher A, Appella E.

AIDS Res Hum Retroviruses. 2003 Feb;19(2):91-101.

PMID:
12639244
12.

A human immunodeficiency virus-transgenic mouse model for assessing interventions that block microbial-induced proviral expression.

Schito ML, Kennedy PE, Kowal RP, Berger EA, Sher A.

J Infect Dis. 2001 Jun 1;183(11):1592-600. Epub 2001 May 1.

PMID:
11343207
13.

Partial characterization of a non-proteinaceous, low molecular weight antigen of Eimeria tenella.

Barta JR, Tennyson SA, Schito ML, Danforth HD, Martin DS.

Parasitol Res. 2000 Jun;86(6):461-6.

PMID:
10894471
15.
16.

Analysis of infraspecific variation among five strains of Eimeria maxima from North America.

Barta JR, Coles BA, Schito ML, Fernando MA, Martin A, Danforth HD.

Int J Parasitol. 1998 Mar;28(3):485-92.

PMID:
9559366
17.
18.

Comparison of four murine Eimeria species in immunocompetent and immunodeficient mice.

Schito ML, Barta JR, Chobotar B.

J Parasitol. 1996 Apr;82(2):255-62.

PMID:
8604093

Supplemental Content

Loading ...
Support Center